GABRA1-related disorders: from genetic to functional pathways

Research output: Contribution to journalJournal articleResearchpeer-review

  • Elisa Musto
  • Vivian W Y Liao
  • Katrine M Johannesen
  • Christina D Fenger
  • Damien Lederer
  • Kavitha Kothur
  • Katrina Fisk
  • Bruce Bennetts
  • Pascal Vrielynck
  • Delphine Delaby
  • Berten Ceulemans
  • Sarah Weckhuysen
  • Peter Sparber
  • Arjan Bouman
  • Simone Ardern-Holmes
  • Christopher Troedson
  • Domenica I Battaglia
  • Himanshu Goel
  • Timothy Feyma
  • Somayeh Bakhtiari
  • Linda Tjoa
  • Martin Boxill
  • Nina Demina
  • Olga Shchagina
  • Elena Dadali
  • Michael Kruer
  • Gaetano Cantalupo
  • Ilaria Contaldo
  • Tilman Polster
  • Bertrand Isidor
  • Stefania M Bova
  • Walid Fazeli
  • Leen Wouters
  • Francesca Darra
  • Elisa Pede
  • Diana Le Duc
  • Rami Abou Jamra
  • Sébastien Küry
  • Jacopo Proietti
  • Niamh McSweeney
  • Elly Brokamp
  • Peter Ian Andrews
  • Marie Gouray Garcia
  • Mary Chebib
  • Rikke S Møller
  • Philip K Ahring
  • Elena Gardella

OBJECTIVE: Variants in GABRA1 have been associated with a broad epilepsy spectrum, ranging from genetic generalized epilepsies to developmental and epileptic encephalopathies. However, our understanding of what determines the phenotype severity and best treatment options remains inadequate. We therefore aimed to analyse the electro-clinical features and the functional effects of GABRA1-variants to establish genotype-phenotype correlations.

METHODS: Genetic and electro-clinical data of 27 individuals (22 unrelated and 2 families) harbouring 20 different GABRA1 variants were collected and accompanied with functional analysis of 19 variants.

RESULTS: Individuals in this cohort could be assigned into different clinical subgroups based on the functional effect of their variant and its structural position within the GABRA1 subunit. A homogenous phenotype with mild cognitive impairment and infantile-onset epilepsy (focal seizures, fever sensitivity and EEG posterior epileptiform discharges) was described for variants in the extra-cellular domain and the small transmembrane loops. These variants displayed loss-of-function (LoF) effects and the patients generally had a favourable outcome. A more severe phenotype was associated with variants in the pore-forming transmembrane helices. These variants displayed either gain-of-function (GoF) or LoF effects. GoF-variants were associated with severe early-onset neurodevelopmental disorders, including early infantile developmental and epileptic encephalopathy.

INTERPRETATION: Our data expand the genetic and phenotypic spectrum of GABRA1-epilepsies and permit to delineate specific sub-phenotypes for LoF and GoF variants, though the heterogeneity of phenotypes and variants. Generally, variants in the transmembrane helices cause more severe phenotypes, in particular GoF variants. These findings establish the basis for a better understanding of the patho-mechanism and precision medicine approach in GABRA1-related disorders. Further studies in larger populations are needed to provide a conclusive genotype-phenotype correlation. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalAnnals of Neurology
Volume95
Issue number1
Pages (from-to)27-41
Number of pages15
ISSN0364-5134
DOIs
Publication statusPublished - 2024

Bibliographical note

This article is protected by copyright. All rights reserved.

ID: 368136014